Late-onset fatal acute leucoencephalopathy in liver transplant recipient [3]

Lancet

Volumn 349, Issue 9069, 1996, Pages 1884-1885

  Fisher, N C ^a   Ruban, E ^a   Carey, M ^a   Heafield, M T E ^a   West, R J ^a   Adams, D H ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; TACROLIMUS;

BILE DUCT OBSTRUCTION; DIARRHEA; GRAND MAL SEIZURE; HUMAN; JAUNDICE; LETTER; LEUKOENCEPHALOPATHY; LIVER TRANSPLANTATION; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECTAL DRUG ADMINISTRATION; SCLEROSING CHOLANGITIS;

EID: 0030604556     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)63875-5     Document Type: Article

References (5)

1. 1 Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334: 494-500.
2. 2 Pullicino P, Zimmer W, Kwen PL, et al. Posterior leukoencephalopathy syndrome. Lancet 1996; 347: 1556-57.
3. 3 Boon AP, Adams DH, Carey MP, et al. Cyclosporin-associated cerebral lesions in liver transplantation. Lancet 1988; i: 1457.
4. 4 De Groen PC, Aksamit AJ, Rakela J, Krom RAF. Cyclosporin-associated central nervous system neurotoxicity. N Engl J Med 1988; 318: 789.
5. 5 Levy GA, Grant D, Neoral in liver transplantation. Transpl Proc 1996; 28: 1019-21.